| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.2 | 4e-08 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | 0.25 | 3e-06 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | 0.17 | 5e-06 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.17 | 9e-06 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | 0.15 | 9e-06 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | 0.14 | 2e-05 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.17 | 3e-05 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | 0.22 | 4e-05 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | 0.12 | 6e-05 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.22 | 6e-05 |